Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT02021422 2026-02-18

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms